Medivolve, a publicly traded company, is dedicated to combating COVID-19 by seeking out disruptive technologies, ground-breaking innovations, and exclusive partnerships. Their Collection Sites locations offer a range of COVID-19 testing options, including rapid antigen tests, rapid antibody tests, and PCR tests, with results provided by CLIA certified labs. Medivolve's testing services cover viral detection and antibody testing, providing accurate results with quick turnaround times.
With a focus on high-quality patient care, Medivolve's rapid antigen tests are ideal for individuals experiencing COVID-19 symptoms, while their rapid antibody tests detect the presence of COVID-19 antibodies in the bloodstream. The gold standard PCR tests can detect the virus within days of infection, even in asymptomatic individuals. Medivolve's commitment to public health safety is evident in their acceptance of all insurance carriers and their dedication to providing certified results through their HIPAA-compliant Medivolve Patient Portal.
Generated from the website